Literature DB >> 1127264

The spectrum of colitis associated with lincomycin and clindamycin therapy.

J L Le Frock, A S Klainer, S Chen, R B Gainer, M Omar, W Anderson.   

Abstract

Ten cases of protracted diarrheal illness after the oral administration of lincomycin or clindamycin in standard dosages were observed in previously healthy subjects. An abrupt onset of diarrhea, crampy abdominal pain, fever, and leukocytosis was observed one to 12 days after discontinuation of the drug. Proctoscopic examination revealed erythematous friable mucosa covered with small raised, yellowish-white plaques that were sometimes confluent. Barium contrast studies of the colon demonstrated irregular shaggy mucosa, ulcerations, cobblestone appearance, and thumb printing. Rectal bipsy showed acute inflammation with pseudomembranes with focal or superficial ulcerations. All patients had a protracted course but recovered with supportive management. Follow-up barium enemas and proctoscopy were done on all patients and were normal. A history of diarrhea, fever, and mucosal changes seen on proctoscopy in a patient who has recently received one of these antibiotics should raise the possibility of colitis associated with clindamycin and lincomycin therapy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1127264     DOI: 10.1093/infdis/131.supplement.s108

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Antibiotic-induced diarrhoea.

Authors:  E R Smith; S J Goulston
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  Pseudomembranous colitis.

Authors:  A B Price; D R Davies
Journal:  J Clin Pathol       Date:  1977-01       Impact factor: 3.411

3.  Recurrent colitis following antibiotic-associated pseudomembranous colitis.

Authors:  J Davies; E Beck
Journal:  Postgrad Med J       Date:  1981-09       Impact factor: 2.401

4.  Induction of Escherichia coli and Vibrio cholerae enterotoxins by an inhibitor of protein synthesis.

Authors:  M Levner; F P Wiener; B A Rubin
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

Review 5.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

6.  Purification and characterization of Clostridium difficile toxin.

Authors:  R D Rolfe; S M Finegold
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.